Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin with Chemoradiation in Rectal Cancer
NCT02569645Phase 2Completed
- Sponsor
- American Health Staffing Group
- Start
- Nov 2015
- Primary completion
- Sep 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of rosuvastatin in rectal cancer, sponsored by American Health Staffing Group. Primary endpoint: Pathological Complete Response Rate up to 3 years. Started Nov 2015; status: completed.
02
Drugs
rosuvastatin
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT02569645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02569645.